Disclosures for "An Illustrative Case of Daratumumab-associated Leukoencephalopathy: A Rare but Important Complication of Anti-CD38 Therapy in Multiple Myeloma Patients"
-
Dr. Jia has nothing to disclose.
-
Dr. Balabanov has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Balabanov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Balabanov has received research support from NextCure. The institution of Dr. Balabanov has received research support from Biogen. The institution of Dr. Balabanov has received research support from NINDS.
-
An immediate family member of Dr. May has received personal compensation for serving as an employee of Doximity. An immediate family member of Dr. May has stock in Doximity.
-
Dr. Dixit has nothing to disclose.
-
Dr. Mehta has nothing to disclose.
-
The institution of Dr. Kimchi has received research support from NIH. The institution of an immediate family member of Dr. Kimchi has received research support from NIH.